408 related articles for article (PubMed ID: 32485534)
1. Iodoquinazolinones bearing benzenesulfonamide as human carbonic anhydrase I, II, IX and XII inhibitors: Synthesis, biological evaluation and radiosensitizing activity.
Soliman AM; Ghorab MM; Bua S; Supuran CT
Eur J Med Chem; 2020 Aug; 200():112449. PubMed ID: 32485534
[TBL] [Abstract][Full Text] [Related]
2. Biological evaluation, radiosensitizing activity and structural insights of novel halogenated quinazoline-sulfonamide conjugates as selective human carbonic anhydrases IX/XII inhibitors.
Ghorab MM; Soliman AM; Bua S; Supuran CT
Bioorg Chem; 2021 Feb; 107():104618. PubMed ID: 33485104
[TBL] [Abstract][Full Text] [Related]
3. Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine-Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors.
Abdel-Mohsen HT; El Kerdawy AM; Omar MA; Petreni A; Allam RM; El Diwani HI; Supuran CT
Eur J Med Chem; 2022 Jan; 228():114004. PubMed ID: 34847409
[TBL] [Abstract][Full Text] [Related]
4. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
[TBL] [Abstract][Full Text] [Related]
5. S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors.
El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Alanazi MM; El-Gendy MA; Ahmed HEA; Supuran CT
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):733-743. PubMed ID: 32189526
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
Sławiński J; Szafrański K; Vullo D; Supuran CT
Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and selective inhibitory effects of some 2-oxindole benzenesulfonamide conjugates on human carbonic anhydrase isoforms CA I, CA II, CA IX and CAXII.
George RF; Said MF; Bua S; Supuran CT
Bioorg Chem; 2020 Jan; 95():103514. PubMed ID: 31887473
[TBL] [Abstract][Full Text] [Related]
9. Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and
Abdelrahman MA; Eldehna WM; Nocentini A; Ibrahim HS; Almahli H; Abdel-Aziz HA; Abou-Seri SM; Supuran CT
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):298-305. PubMed ID: 31809607
[TBL] [Abstract][Full Text] [Related]
10. Benzenesulfonamide bearing 1,2,4-triazole scaffolds as potent inhibitors of tumor associated carbonic anhydrase isoforms hCA IX and hCA XII.
SitaRam ; Celik G; Khloya P; Vullo D; Supuran CT; Sharma PK
Bioorg Med Chem; 2014 Mar; 22(6):1873-82. PubMed ID: 24560737
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation and in silico modelling studies of 1,3,5-trisubstituted pyrazoles carrying benzenesulfonamide as potential anticancer agents and selective cancer-associated hCA IX isoenzyme inhibitors.
Yamali C; Gul HI; Ece A; Bua S; Angeli A; Sakagami H; Sahin E; Supuran CT
Bioorg Chem; 2019 Nov; 92():103222. PubMed ID: 31499260
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of novel carbohydrate-based sulfonamide derivatives as antitumor agents.
Hao S; Cheng X; Wang X; An R; Xu H; Guo M; Li C; Wang Y; Hou Z; Guo C
Bioorg Chem; 2020 Nov; 104():104237. PubMed ID: 32911194
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties.
Ghorab MM; Alsaid MS; Ceruso M; Nissan YM; Supuran CT
Bioorg Med Chem; 2014 Jul; 22(14):3684-95. PubMed ID: 24878360
[TBL] [Abstract][Full Text] [Related]
14. Insertion of metal carbenes into the anilinic N-H bond of unprotected aminobenzenesulfonamides delivers low nanomolar inhibitors of human carbonic anhydrase IX and XII isoforms.
Sharonova T; Paramonova P; Kalinin S; Bunev A; Gasanov RЕ; Nocentini A; Sharoyko V; Tennikova TB; Dar'in D; Supuran CT; Krasavin M
Eur J Med Chem; 2021 Jun; 218():113352. PubMed ID: 33774343
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of a new series of N⁴-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
Sławiński J; Brzozowski Z; Żołnowska B; Szafrański K; Pogorzelska A; Vullo D; Supuran CT
Eur J Med Chem; 2014 Sep; 84():59-67. PubMed ID: 25016228
[TBL] [Abstract][Full Text] [Related]
16. Tailored Tetrasubstituted Imidazole Carrying the Benzenesulfonamide Fragments as Selective Human Carbonic Anhydrase IX/XII Inhibitors.
Taher ES; Marzouk AA; Abd-Allah WH; Giovannuzzi S; Ibrahim TS; Supuran CT; El Hamd MA; El-Behairy MF
ChemMedChem; 2024 May; 19(10):e202400004. PubMed ID: 38356418
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, molecular modelling and QSAR study of new
Said MF; George RF; Petreni A; Supuran CT; Mohamed NM
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):701-717. PubMed ID: 35168458
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors. Synthesis of a novel series of 5-substituted 2,4-dichlorobenzenesulfonamides and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
Sławiński J; Pogorzelska A; Żołnowska B; Brożewicz K; Vullo D; Supuran CT
Eur J Med Chem; 2014 Jul; 82():47-55. PubMed ID: 24871996
[TBL] [Abstract][Full Text] [Related]
19. Identification of N-phenyl-2-(phenylsulfonyl)acetamides/propanamides as new SLC-0111 analogues: Synthesis and evaluation of the carbonic anhydrase inhibitory activities.
Elbadawi MM; Eldehna WM; Nocentini A; Abo-Ashour MF; Elkaeed EB; Abdelgawad MA; Alharbi KS; Abdel-Aziz HA; Supuran CT; Gratteri P; Al-Sanea MM
Eur J Med Chem; 2021 Jun; 218():113360. PubMed ID: 33773285
[TBL] [Abstract][Full Text] [Related]
20. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform.
Ibrahim HS; Allam HA; Mahmoud WR; Bonardi A; Nocentini A; Gratteri P; Ibrahim ES; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2018 May; 152():1-9. PubMed ID: 29684705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
